Supervisory Board

Benoit Barteau

Board member

Benoit BARTEAU (PhD) is Senior Investment Manager in the Life Sciences Department of Bpifrance Investissement. Since 2014, he has been involved in around 10 investment deals. Prior to Bpifrance, Benoit has gained over 7 years...

Frédéric Chereau

Board member

Frederic Chereau currently serves as President and Chief Executive Officer of LogicBio Therapeutics. From 2014 to 2015, Mr. Chereau was President and Chief Operating Officer of aTyr Pharma (LIFE). During his tenure, the company advanced multiple...

Rémi Droller

Board member

Rémi Droller has a master’s degree in Molecular Biology (Paris VI) and master’s degree in Finance and Innovation Management (Masternova – AgroPariTech). He started at CDC Innovation from 2000 to 2003 and later joined AGF Private...

Georges Gemayel

Chairman

Georges Gemayel has 30 years of experience in the biopharmaceutical industry. He serves currently as Chairman of the Board of Directors of Dynacure, Oxthera, Enterome and Orphazyme.  Georges serves also as Director of Momenta Pharmaceuticals...

Laurent Higueret

Board observer

Laurent is a Senior Investment Director in the Large Venture Fund at Bpifrance, the VC arm of the Public Investment Bank of France, in charge of healthcare and life sciences investments. He currently serves as...

Ellen Hukkelhoven

Board observer

Ellen Hukkelhoven joined Perceptive in 2013 and is a Managing Director on the investment team. At Perceptive, she focuses on public and private development stage therapeutic companies. Ellen serves on the boards of MeiraGTx, Freenome,...

Chris Mirabelli

Board member

Chris Mirabelli (PhD) has served as the Chairman of the Board of Directors of Leap Therapeutics (LPTX) since 2016 and has also served as the President and Chief Executive Officer since the company’s inception in 2011....

Brett P. Monia

Board member

Dr. Monia is the chief executive officer and a founding member of Ionis Pharmaceuticals. His contributions at Ionis include research into the medicinal chemistry and mechanisms of action of RNA-targeting modalities to treat human diseases,...

Henri Skinner

Board Member

Dr. Skinner is Senior Vice President, Venture at Tekla Capital Management.  Prior to joining Tekla, Dr. Skinner Served as Deputy Head and Managing Director of Novartis Venture Fund.  In addition, Dr. Skinner has been CEO...

Stéphane van Rooijen

Board member

Stephane van Rooijen (MD, MBA) is a general management biotech executive with in-depth experience in life sciences working across European and North American organizations. He studied medicine at KU Leuven and obtained an MBA at Erasmus...

Raphael Wisniewski

Board Member

Raphael joined the Life Sciences Team of Andera Partners (formerly Edmond de Rothschild Investment Partners) in 2001. Previously, he worked in Healthcare Corporate Finance at Goldman Sachs starting at Salomon Smith Barney. He worked also...